Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H2CF
|
|||
| Former ID |
DNCL002506
|
|||
| Drug Name |
Anti-MUC1 mab
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Pancreatic cancer [ICD-11: 2C10] | Phase 1 | [1] | |
| Company |
Quest PharmaTech
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mucin-1 (MUC1) | Target Info | Modulator | [2] |
| WikiPathways | Hematopoietic Stem Cell Differentiation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Quest PharmaTech. | |||
| REF 2 | Characterization of an anti-MUC1 monoclonal antibody with potential as a cancer vaccine. Hybrid Hybridomics. 2001;20(5-6):313-24. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.